Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Videos
Diagnostics
In Vitro Diagnostics
Return to: MDBR Home | Diagnostics | In Vitro Diagnostics | News
Search Refinements

In Vitro Diagnostics News

View news from other Medical Devices sectors:
571-585 of 2993 results
Netherlands’ LabPON deploys Philips IntelliSite Pathology Solution
By MDBR Staff Writer
Netherlands-based LabPON has deployed Royal Philips’ IntelliSite Pathology Solution, transitioning completely to digital diagnosis.
Diagnostics > In Vitro Diagnostics > News
QIAGEN expands QIAsymphony test menu in partnership with Seegene
By MDBR Staff Writer
QIAGEN announced a collaboration in which Seegene will develop a menu of multiplex assay panels for its modular QIAsymphony RGQ MDx automation platform.
Diagnostics > In Vitro Diagnostics > News
Asuragen introduces new Quantidex Pan Cancer kit
By MDBR Staff Writer
Molecular diagnostics firm Asuragen has introduced new Quantidex Pan Cancer Kit, a workflow solution for targeted next-generation sequencing (NGS).
Diagnostics > In Vitro Diagnostics > News
Moleculera Labs receives grant from OCAST to develop assays
By MDBR Staff Writer
Moleculera Labs announced the receipt of a two-year, $300,000 matching grant from the Oklahoma Center for the Advancement of Science and Technology (OCAST).
Diagnostics > In Vitro Diagnostics > News
Theranos obtains FDA approval for HSV-1 test
By MDBR Staff Writer
Health technology firm Theranos has obtained approval from the US Food and Drug Administration (FDA) for its test system and test for herpes simplex 1 virus (HSV-1) IgG.
Diagnostics > In Vitro Diagnostics > News
SeraCare Life, NCI partner to develop controls for cancer assays
By MDBR Staff Writer
Vitro diagnostics manufacturer SeraCare Life Sciences will develop reference materials and positive controls for cancer assays, under a partnership with the National Cancer Institute (NCI).
Diagnostics > In Vitro Diagnostics > News
Boston IVF and IviGen partner to improve fertility outcomes
By MDBR Staff Writer
Boston IVF, a provider of in vitro fertilization services in the US, IviGen and its parent company iGenomix, worldwide providers of advanced services in reproductive genetics, have announced a partnership which will provide comprehensive genetic testing services to Boston IVF patients.
Diagnostics > In Vitro Diagnostics > News
S-BIO launches new kit for O-Glycan analysis
By MDBR Staff Writer
S-BIO, a unit of Sumitomo Bakelite, has launched BlotGlyco O-Glycan Sample Preparation Kit that will analyze O-glycans in biological samples and biotherapeutic glycoproteins.
Diagnostics > In Vitro Diagnostics > News
Roche and Global Fund partner for HIV diagnostic technologies
By MDBR Staff Writer
Switzerland-based Roche has agreed to provide HIV-1 viral load and early infant diagnostic technologies for the Global Fund.
Diagnostics > In Vitro Diagnostics > News
Hill-Rom to buy Welch Allyn for $2.05bn
By MDBR Staff Writer
Medical technology firm Hill-Rom Holdings has signed an agreement to acquire US-based Welch Allyn, for around $2.05bn in cash and stock.
Diagnostics > In Vitro Diagnostics > News
handyem and FlowMetric Diagnostics announce partnership in development of flow cytometry-based solutions in diagnostic capabilities
By MDBR Staff Writer
handyem and FlowMetric Diagnostics announce their partnership centralized around the incorporation of handyem's HPC-150 portable flow cytometer within FlowMetric Diagnostics' mobile point-of-care diagnostic laboratory, the Mo-POD.
Diagnostics > In Vitro Diagnostics > News
Castle Biosciences announces national payer agreements with MultiPlan, FedMed and Preferred Medical Claim Solutions
By MDBR Staff Writer
Castle Biosciences, a provider of molecular diagnostics to improve cancer treatment decisions, today announced the Company has secured payer contracts with national provider networks MultiPlan, FedMed and Preferred Medical Claim Solutions to provide coverage of its DecisionDx assays.
Diagnostics > In Vitro Diagnostics > News
Quanterix names PBL Assay Science as preferred partner in assay development and testing services
By MDBR Staff Writer
Quanterix , a leader in high definition diagnostics, delivering ultrasensitive single molecule measurement for the benefit of human health, today announced an alliance with PBL Assay Science (PBL), naming the Company as a Preferred Partner for assay research and development.
Diagnostics > In Vitro Diagnostics > News
BioLight and Ora to develop TeaRx diagnostic test for dry eye syndrome
By MDBR Staff Writer
BioLight Life Sciences Investments has entered into a collaboration agreement with Ora to enhance the clinical, regulatory and commercial development of its TeaRx multi-parameter diagnostic test for dry eye syndrome (DES).
Diagnostics > In Vitro Diagnostics > News
Ventana ALK CDx assay obtains FDA approval to identify lung cancer patients
By MDBR Staff Writer
Roche Group subsidiary Ventana Medical Systems has received approval from the US Food and Drug Administration (FDA) for its ALK (D5F3) CDx assay for use as a companion diagnostic to identify lung cancer patients for Pfizer's FDA approved targeted therapy Xalkori (crizotinib).
Diagnostics > In Vitro Diagnostics > News
571-585 of 2993 results